About
Rare Disease Treatments
Areas of Focus
Categories
Biologics & BiopharmaceuticalVirginia, DC, DE & Maryland
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
716
By Phase
PHASE4: 2PHASE3: 1
By Status
RECRUITING: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06268769Collaborator
Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs
PHASE4Recruiting
300 participants
Started: Mar 9, 2024 · Completed: Sep 30, 2029
NCT05696613Lead Sponsor
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
PHASE3Recruiting
148 participants
Started: Mar 13, 2023 · Completed: Mar 1, 2026
NCT04720326Collaborator
Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients
PHASE4Active, not recruiting
268 participants
Started: Dec 23, 2020 · Completed: Oct 31, 2026
Locations (1)
Headquarters
Gaithersburg, MD, United States
Map
Loading map...